Showing 2,829 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Injectable & long-acting PrEP

Black Gay Men and Trans Women Are Well Protected by Injectable PrEP

Editor's pick
POZ
21 March 2023
PrEP programmes & uptake

Strong support systems tied to PrEP adherence among adolescent girls and young women in South Africa

News
21 March 2023
Government, leadership & policy

Hopeful HIV and Hepatitis News in Biden’s Proposed 2024 Budget

Editor's pick
POZ
20 March 2023
Injectable & long-acting HIV treatment

Top 5 stories on injectable HIV treatment and PrEP from CROI 2023

News
15 March 2023
New & experimental HIV treatments

Top 5 stories on new drugs for HIV prevention and treatment from CROI 2023

News
14 March 2023
Access to healthcare

Top 5 stories on HIV in Africa from CROI 2023

News
10 March 2023
PrEP

CROI 2023: Bone density profiles for long-acting cabotegravir vs TDF/FTC oral PrEP in young people

Editor's pick
i-Base
9 March 2023
Sexual health

Top 5 stories on sexual health from CROI 2023

News
9 March 2023
Women

Women are being failed in the fight against HIV

Editor's pick
National AIDS Trust
8 March 2023
PrEP programmes & uptake

High resilience linked to high PrEP use among Canadian men who have sex with men

Editor's pick
AJMC
6 March 2023
Young people

New study reveals parents' concerns about their sexual and gender minority teens using PrEP for HIV prevention

Editor's pick
Medical Xpress
2 March 2023
Injectable & long-acting PrEP

CROI 2023: Islatravir implant for PrEP Video

March 2023
Injectable & long-acting PrEP

Experimental islatravir implants protect monkeys against HIV-like virus

News
1 March 2023
PrEP programmes & uptake

Tenofovir disoproxil-based pill regains its position as first choice for PrEP in the US

News
1 March 2023
PrEP programmes & uptake

Huge increase in PrEP uptake when services offer choice and flexibility, African studies show

News
28 February 2023
Government, leadership & policy

What Will Happen to Tennessee HIV/AIDS Groups After Their State Government Takes Away Federal Funding?

Editor's pick
TheBody
28 February 2023
Injectable & long-acting PrEP

Long-Acting CAB for PrEP Acceptable, Safe in Adolescent Female Africans

Editor's pick
NATAP
27 February 2023
PrEP science

HIV infections acquired while on injectable PrEP may take a very long time to be spotted

News
27 February 2023
Vaginal rings & topical PrEP

Promising new PrEP method undergoes first safety study for anal sex

News
24 February 2023
Injectable & long-acting PrEP

Modeling study shows that long-acting injectable cabotegravir has the potential to significantly reduce new HIV infections

Editor's pick
Clinton Health Access Initiative
23 February 2023
Injectable & long-acting PrEP

Good news for women and PrEP: quarterly dosing may work

News
23 February 2023
Injectable & long-acting PrEP

Large Benefit With Long-Acting PrEP in Black People, but Some HIV Risk Persists

Editor's pick
MedPage Today
22 February 2023
Vaginal rings & topical PrEP

Dapivirine vaginal ring safe to use in third trimester of pregnancy and during breastfeeding

News
21 February 2023
Sexually transmitted infections prevention

Vaccine halves gonorrhoea rate in French study

News
20 February 2023